Payment overview · 2025
General Payments
$176.35
2 reported records · 1 companies
Healthcare provider profile · identity verified
Preeti Modi
Allopathic & Osteopathic Physicians|Internal Medicine · SPRINGFIELD, MO · NPI 1922261114
Verified facts
What the public records show
CMS Open Payments records show Preeti Modi received $176.35 in general payments during 2025 across 2 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $176.35 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $175.00 | 1 |
| Food and Beverage | $1.35 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $175.00 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $1.35 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 767 | 202 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 713 | 205 |
| Atorvastatin Calcium | Atorvastatin Calcium | 588 | 159 |
| Pantoprazole Sodium | Pantoprazole Sodium | 422 | 119 |
| Amlodipine Besylate | Amlodipine Besylate | 415 | 123 |
| Metoprolol Succinate | Metoprolol Succinate | 314 | 88 |
| Trazodone Hcl | Trazodone Hcl | 313 | 83 |
| Gabapentin | Gabapentin | 309 | 92 |
| Montelukast Sodium | Montelukast Sodium | 306 | 81 |
| Lisinopril | Lisinopril | 257 | 71 |
| Losartan Potassium | Losartan Potassium | 254 | 72 |
| Potassium Chloride | Potassium Chloride | 248 | 65 |
| Duloxetine Hcl | Duloxetine Hcl | 232 | 51 |
| Hydrochlorothiazide | Hydrochlorothiazide | 223 | 68 |
| Omeprazole | Omeprazole | 201 | 66 |
| Buspirone Hcl | Buspirone Hcl | 195 | 48 |
| Furosemide | Furosemide | 191 | 54 |
| Sertraline Hcl | Sertraline Hcl | 186 | 50 |
| Tramadol Hcl | Tramadol Hcl | 186 | 62 |
| Eliquis | Apixaban | 184 | 39 |
| Metoprolol Tartrate | Metoprolol Tartrate | 169 | 50 |
| Alendronate Sodium | Alendronate Sodium | 167 | 52 |
| Escitalopram Oxalate | Escitalopram Oxalate | 164 | 43 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 161 | 64 |
| Alprazolam | Alprazolam | 158 | 54 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 156 | 58 |
| Metformin Hcl Er | Metformin Hcl | 148 | 45 |
| Famotidine | Famotidine | 142 | 50 |
| Mounjaro | Tirzepatide | 139 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 136 | 49 |
| Donepezil Hcl | Donepezil Hcl | 126 | 29 |
| Ozempic | Semaglutide | 118 | 25 |
| Carvedilol | Carvedilol | 117 | 36 |
| Clopidogrel | Clopidogrel Bisulfate | 112 | 35 |
| Simvastatin | Simvastatin | 111 | 32 |
| Metformin Hcl | Metformin Hcl | 110 | 33 |
| Bupropion Xl | Bupropion Hcl | 107 | 26 |
| Tizanidine Hcl | Tizanidine Hcl | 106 | 40 |
| Telmisartan | Telmisartan | 105 | 35 |
| Fluoxetine Hcl | Fluoxetine Hcl | 102 | 21 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 94 | 74 |
| Pregabalin | Pregabalin | 94 | 22 |
| Bupropion Hcl Sr | Bupropion Hcl | 92 | 28 |
| Solifenacin Succinate | Solifenacin Succinate | 91 | 27 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 90 | 26 |
| Baclofen | Baclofen | 84 | 28 |
| Ezetimibe | Ezetimibe | 84 | 27 |
| Tamsulosin Hcl | Tamsulosin Hcl | 82 | 29 |
| Spironolactone | Spironolactone | 76 | 23 |
| Allopurinol | Allopurinol | 68 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 68 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 68 | 17 |
| Valsartan | Valsartan | 67 | 17 |
| Breo Ellipta | Fluticasone/Vilanterol | 66 | 20 |
| Zolpidem Tartrate | Zolpidem Tartrate | 63 | 19 |
| Warfarin Sodium | Warfarin Sodium | 61 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 60 | 19 |
| Irbesartan | Irbesartan | 59 | 17 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 56 | 46 |
| Synthroid | Levothyroxine Sodium | 56 | 15 |
| Ondansetron Odt | Ondansetron | 55 | 30 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 55 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 54 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 54 | 20 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 53 | 13 |
| Xarelto | Rivaroxaban | 53 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 51 | 14 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 50 | 11 |
| Myrbetriq | Mirabegron | 50 | 12 |
| Prednisone | Prednisone | 50 | 33 |
| Amitriptyline Hcl | Amitriptyline Hcl | 49 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 48 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 47 | 16 |
| Mirtazapine | Mirtazapine | 46 | 13 |
| Ketoconazole | Ketoconazole | 44 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | 13 |
| Memantine Hcl | Memantine Hcl | 44 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 43 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 42 | 12 |
| Cefdinir | Cefdinir | 41 | 32 |
| Clonazepam | Clonazepam | 41 | 13 |
| Fluconazole | Fluconazole | 41 | 27 |
| Jardiance | Empagliflozin | 41 | 12 |
| Benazepril Hcl | Benazepril Hcl | 40 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | 11 |
| Glipizide Er | Glipizide | 40 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | 13 |
| Acyclovir | Acyclovir | 38 | 15 |
| Sumatriptan Succinate | Sumatriptan Succinate | 38 | 12 |
| Azelastine Hcl | Azelastine Hcl | 37 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 37 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 37 | 11 |
| Propranolol Hcl Er | Propranolol Hcl | 37 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 36 | 13 |
| Lovastatin | Lovastatin | 35 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 34 | 34 |
| Atenolol | Atenolol | 34 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 34 | 24 |
| Topiramate | Topiramate | 34 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 33 | 13 |
| Azithromycin | Azithromycin | 32 | 26 |
| Celecoxib | Celecoxib | 32 | 12 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 31 | suppressed |
| Nystatin | Nystatin | 31 | 15 |
| Dilt-Xr | Diltiazem Hcl | 29 | suppressed |
| Estradiol | Estradiol | 29 | suppressed |
| Finasteride | Finasteride | 28 | 11 |
| Linzess | Linaclotide | 28 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 28 | 11 |
| Lorazepam | Lorazepam | 27 | 11 |
| Meloxicam | Meloxicam | 27 | 13 |
| Tresiba Flextouch U-200 | Insulin Degludec | 27 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 26 | 26 |
| Bumetanide | Bumetanide | 26 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 26 | suppressed |
| Repatha Sureclick | Evolocumab | 26 | suppressed |
| Rybelsus | Semaglutide | 26 | suppressed |
| Glipizide | Glipizide | 25 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Chlorthalidone | Chlorthalidone | 23 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 23 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 23 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 23 | 13 |
| Paxlovid | Nirmatrelvir/Ritonavir | 23 | 22 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 16 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 22 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 22 | suppressed |
| Ramipril | Ramipril | 22 | suppressed |
| Sucralfate | Sucralfate | 22 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 22 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 22 | 14 |
| Glimepiride | Glimepiride | 21 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 20 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Metronidazole | Metronidazole | 20 | suppressed |
| Olanzapine | Olanzapine | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 19 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Eszopiclone | Eszopiclone | 18 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 18 | suppressed |
| Klor-Con M20 | Potassium Chloride | 18 | suppressed |
| Mupirocin | Mupirocin | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Cephalexin | Cephalexin | 16 | 12 |
| Nitroglycerin | Nitroglycerin | 16 | 14 |
| Tradjenta | Linagliptin | 16 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 15 |
| Lidocaine | Lidocaine | 15 | suppressed |
| Praluent Pen | Alirocumab | 15 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 15 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Cresemba | Isavuconazonium Sulfate | 13 | suppressed |
| Febuxostat | Febuxostat | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 12 | suppressed |
| Qulipta | Atogepant | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Diazepam | Diazepam | 11 | 11 |
| Dulera | Mometasone/Formoterol | 11 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | 11 |
| Prenatal Vitamin Plus Low Iron | Pnv,calcium 72/Iron/Folic Acid | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $176.35 · 2 records | Amgen Inc. | PROLIA, REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error